advanced
Showing 9976 - 10000 of >10,000
Advanced Gastric Adenocarcinoma Trial in Fuzhou (Camrelizumab, Apatinib Mesylate, POF)
Unknown status
- Advanced Gastric Adenocarcinoma
- Camrelizumab
- +2 more
-
Fuzhou, ChinaRongbo Lin
Nov 21, 2019
Breast Cancer Trial in Worldwide (Fulvestrant, GDC-0810)
Terminated
- Breast Cancer
-
New Haven, Connecticut
- +43 more
Apr 21, 2021
Advanced Breast Cancer, Metastatic Breast Cancer Trial in Yerevan (Curcumin, Paclitaxel, Placebo)
Completed
- Advanced Breast Cancer
- Metastatic Breast Cancer
- Curcumin
- +2 more
-
Yerevan, ArmeniaNational Center of Oncology
Nov 25, 2019
End-stage Heart Failure Trial in Beijing (Corheart 6 Left Ventricular Assist System)
Completed
- End-stage Heart Failure
- Corheart 6 Left Ventricular Assist System
-
Beijing, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences
Jun 28, 2023
Renal Cell Cancer, Metastatic Castration Resistant Prostate Cancer Trial in Australia, Canada, United States (Ciforadenant,
Completed
- Renal Cell Cancer
- Metastatic Castration Resistant Prostate Cancer
- Ciforadenant
- Ciforadenant + atezolizumab
-
Tucson, Arizona
- +19 more
Aug 27, 2021
Metastatic Urothelial Cancer Trial in Japan (Enfortumab vedotin)
Completed
- Metastatic Urothelial Cancer
- Enfortumab vedotin
-
Tsukuba, Ibaraki, Japan
- +7 more
Mar 2, 2020
HER2-Positive Solid Tumors Trial (RC48-ADC in combinaton with JS001)
Unknown status
- HER2-Positive Solid Tumors
- RC48-ADC in combinaton with JS001
- (no location specified)
Feb 19, 2020
Immunodeficiency in MS
Unknown status
- Multiple Sclerosis
- +3 more
- No Interventions
-
Franklin, TennesseeAdvanced Neurosciences Institute
Jun 24, 2020
Colorectal Cancer, Lung Cancer Trial in Ottawa, Toronto, Montreal (cediranib maleate, cisplatin, fluorouracil)
Completed
- Colorectal Cancer
- Lung Cancer
- cediranib maleate
- +5 more
-
Ottawa, Ontario, Canada
- +2 more
Apr 6, 2020
NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)
Terminated
- Non-Small Cell Lung Cancer
- +3 more
-
Tucson, Arizona
- +34 more
Oct 11, 2021
Nasopharyngeal Carcinoma Trial in Beijing (Tislelizumab)
Recruiting
- Nasopharyngeal Carcinoma
-
Beijing, Beijing, ChinaNational Cancer Center /National Clinical Research Center for Ca
Jul 4, 2022
Advanced Solid Tumors, Tumors, Advanced Solid Trial in Budapest (Pevonedistat, [14C]-Pevonedistat, Docetaxel)
Completed
- Advanced Solid Tumors, Neoplasms, Advanced Solid
- Pevonedistat
- +4 more
-
Budapest, Hungary
- +1 more
Nov 4, 2019
Ampulla of Vater Adenocarcinoma, Small Intestinal Adenocarcinoma, Stage III Ampulla of Vater Cancer AJCC v8 Trial in Houston
Completed
- Ampulla of Vater Adenocarcinoma
- +9 more
- Bevacizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 1, 2020
Advanced Clinical Practitioner's Experience Developing Clinical
Unknown status
- ACP
- +2 more
- No intervention
-
Sheffield, United KingdomUniversity of Sheffield
Dec 2, 2019
Estrogen-receptor Positive Invasive Metastatic Breast Cancer Trial in Philadelphia (Ruxolitinib, Exemestane)
Completed
- Estrogen-receptor Positive Invasive Metastatic Breast Cancer
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 29, 2020
Metastatic Distal Bile Duct Adenocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Intrahepatic Cholangiocarcinoma Trial
Recruiting
- Metastatic Distal Bile Duct Adenocarcinoma
- +9 more
- Atezolizumab
- +6 more
-
Phoenix, Arizona
- +28 more
Dec 31, 2022
Esophagogastric Junction Disorder, Tumors Trial (chemoradiation with weekly 5Fu and oxaliplatin, Perioperative mFLOT,
Not yet recruiting
- Esophagogastric Junction Disorder
- Neoplasms
- chemoradiation with weekly 5Fu and oxaliplatin
- +2 more
- (no location specified)
Dec 19, 2019
Chronic Kidney Diseases Trial (CKM Jumpstart Tool)
Not yet recruiting
- Chronic Kidney Diseases
- CKM Jumpstart Tool
- (no location specified)
Feb 21, 2023
Metastatic Urothelial Carcinoma Trial in Québec (Bicalutamide 150 mg, Placebo)
Not yet recruiting
- Metastatic Urothelial Carcinoma
- Bicalutamide 150 mg
- Placebo
-
Québec, CanadaCHU de Québec - Université Laval
Sep 6, 2023